ASSESSING THE ROLE OF HIGH-DOSE VITAMIN C IN CRITICALLY ILL PATIENTS WITH COVID-19
Main Article Content
Keywords
COVID-19, High-dose vitamin C, Critically ill, Inflammation, ICU mortality.
Abstract
Introduction: COVID-19 patients in critical condition can suffer a lot of inflammation and oxidative stress, making their prognosis poor. Clinicians propose that HDIVC can be an additional therapy, as its antioxidant and immunomodulatory properties may help patients.
Objective: This study aimed to examine how HDIVC affects the outcomes of critically ill patients with COVID-19.
Materials and Methods: A prospective cohort study was conducted at Department of Pulmonology, Saidu Medical College and Saidu Group of Teaching Hospital Swat, Pakistan, from January, 2024 to June, 2024. Only ill COVID-19 patients treated with usual procedures and either HDIVC or no HDIVC were studied. The team looked at measurable measurements of inflammation and how patients recovered.
Results: After HDIVC administration, the ICU death rate, time spent in the ICU, and mechanical ventilation time were reduced. Among the inflammatory markers, including CRP, D-dimer, and ferritin, levels decreased more in the HDIVC group than in the control group.
Conclusion: HDIVC appears to make treatment safer and more effective for critically ill COVID-19 patients. Repeated larger studies should confirm the results found in this research.
References
2- JamaliMoghadamSiahkali, S., Zarezade, B., Koolaji, S., SeyedAlinaghi, S., Zendehdel, A., Tabarestani, M., Sekhavati Moghadam, E., Abbasian, L., Dehghan Manshadi, S.A., Salehi, M. and Hasannezhad, M., 2021. Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial. European journal of medical research, 26, pp.1-9.
3- Sun, L., Zhao, J.H., Fan, W.Y., Feng, B., Liu, W.W., Chen, R.Q., Ban, C., Dang, A.G., Wang, M., Luo, K.T. and Zhou, G.Y., 2024. Therapeutic effects of high-dose vitamin C supplementation in patients with COVID-19: a meta-analysis. Nutrition Reviews, 82(8), pp.1056-1068.
4- Corrao, S., Raspanti, M., Agugliaro, F., Gervasi, F., Di Bernardo, F., Natoli, G. and Argano, C., 2024. Safety of high-dose vitamin C in non-intensive care hospitalized patients with COVID-19: an open-label clinical study. Journal of Clinical Medicine, 13(13), p.3987.
5- Zhao, B., Ling, Y., Li, J., Peng, Y., Huang, J., Wang, Y., Qu, H., Gao, Y., Li, Y., Hu, B. and Lu, S., 2021. Beneficial aspects of high dose intravenous vitamin C on patients with COVID-19 pneumonia in severe condition: a retrospective case series study. Annals of palliative medicine, 10(2), pp.1599609-1591609.
6- Vollbracht, C. and Kraft, K., 2022. Oxidative stress and hyper-inflammation as major drivers of severe COVID-19 and long COVID: implications for the benefit of high-dose intravenous vitamin C. Frontiers in Pharmacology, 13, p.899198.
7- Gavrielatou, E., Xourgia, E., Xixi, N.A., Mantelou, A.G., Ischaki, E., Kanavou, A., Zervakis, D., Routsi, C., Kotanidou, A. and Siempos, I.I., 2022. Effect of vitamin C on clinical outcomes of critically ill patients with COVID-19: an observational study and subsequent meta-analysis. Frontiers in Medicine, 9, p.814587.
8- Gao, D., Xu, M., Wang, G., Lv, J., Ma, X., Guo, Y., Zhang, D., Yang, H., Jiang, W., Deng, F. and Xia, G., 2021. The efficiency and safety of high-dose vitamin C in patients with COVID-19: a retrospective cohort study. Aging (Albany NY), 13(5), p.7020.
9- Bhowmik, K.K., Barek, M.A., Aziz, M.A. and Islam, M.S., 2022. Impact of high‐dose vitamin C on the mortality, severity, and duration of hospital stay in COVID‐19 patients: A meta‐analysis. Health Science Reports, 5(5), p.e762.
10- Labbani-Motlagh, Z., Amini, S., Aliannejad, R., Sadeghi, A., Shafiee, G., Heshmat, R., Jafary, M., Talaschian, M., Akhtari, M., Jamshidi, A. and Mahmoudi, M., 2022. High-dose intravenous vitamin C in early stages of severe acute respiratory syndrome coronavirus 2 infection: a double-blind, randomized, controlled clinical trial. Journal of Research in Pharmacy Practice, 11(2), pp.64-72.
11- Majidi, N., Rabbani, F., Gholami, S., Gholamalizadeh, M., BourBour, F., Rastgoo, S., Hajipour, A., Shadnoosh, M., Akbari, M.E., Bahar, B. and Ashoori, N., 2021. The effect of vitamin C on pathological parameters and survival duration of critically ill coronavirus disease 2019 patients: a randomized clinical trial. Frontiers in immunology, 12, p.717816.
12- Hess, A.L., Halalau, A., Dokter, J.J., Paydawy, T.S., Karabon, P., Bastani, A., Baker, R.E., Balla, A.K. and Galens, S.A., 2022. High-dose intravenous vitamin C decreases rates of mechanical ventilation and cardiac arrest in severe COVID-19. Internal and emergency medicine, 17(6), pp.1759-1768.
13- Mahmoodpoor, A., Shadvar, K., Sanaie, S., Hadipoor, M.R., Pourmoghaddam, M.A. and Saghaleini, S.H., 2021. Effect of Vitamin C on mortality of critically ill patients with severe pneumonia in intensive care unit: a preliminary study. BMC infectious diseases, 21, pp.1-7.
14- Juneja, D., Gupta, A., Kataria, S. and Singh, O., 2022. Role of high dose vitamin C in management of hospitalised COVID-19 patients: A minireview. World Journal of Virology, 11(5), p.300.
15- Suna, K., Melahat, U.Ş., Murat, Y., Figen, Ö.E. and Ayperi, Ö., 2022. Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia. Medicina Clínica (English Edition), 158(8), pp.356-360.